5-80654689-C-T

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1

The NM_002439.5(MSH3):​c.-39C>T variant causes a 5 prime UTR premature start codon gain change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.166 in 1,560,524 control chromosomes in the GnomAD database, including 23,414 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.13 ( 1639 hom., cov: 32)
Exomes 𝑓: 0.17 ( 21775 hom. )

Consequence

MSH3
NM_002439.5 5_prime_UTR_premature_start_codon_gain

Scores

2

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: -0.00800

Publications

20 publications found
Variant links:
Genes affected
MSH3 (HGNC:7326): (mutS homolog 3) The protein encoded by this gene forms a heterodimer with MSH2 to form MutS beta, part of the post-replicative DNA mismatch repair system. MutS beta initiates mismatch repair by binding to a mismatch and then forming a complex with MutL alpha heterodimer. This gene contains a polymorphic 9 bp tandem repeat sequence in the first exon. The repeat is present 6 times in the reference genome sequence and 3-7 repeats have been reported. Defects in this gene are a cause of susceptibility to endometrial cancer. [provided by RefSeq, Mar 2011]
DHFR (HGNC:2861): (dihydrofolate reductase) Dihydrofolate reductase converts dihydrofolate into tetrahydrofolate, a methyl group shuttle required for the de novo synthesis of purines, thymidylic acid, and certain amino acids. While the functional dihydrofolate reductase gene has been mapped to chromosome 5, multiple intronless processed pseudogenes or dihydrofolate reductase-like genes have been identified on separate chromosomes. Dihydrofolate reductase deficiency has been linked to megaloblastic anemia. Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Mar 2014]
DHFR Gene-Disease associations (from GenCC):
  • constitutional megaloblastic anemia with severe neurologic disease
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.75).
BP6
Variant 5-80654689-C-T is Benign according to our data. Variant chr5-80654689-C-T is described in ClinVar as Benign. ClinVar VariationId is 1220684.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.23 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MSH3NM_002439.5 linkc.-39C>T 5_prime_UTR_premature_start_codon_gain_variant Exon 1 of 24 ENST00000265081.7 NP_002430.3
MSH3NM_002439.5 linkc.-39C>T 5_prime_UTR_variant Exon 1 of 24 ENST00000265081.7 NP_002430.3
DHFRNM_000791.4 linkc.-200G>A 5_prime_UTR_variant Exon 1 of 6 ENST00000439211.7 NP_000782.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MSH3ENST00000265081.7 linkc.-39C>T 5_prime_UTR_premature_start_codon_gain_variant Exon 1 of 24 1 NM_002439.5 ENSP00000265081.6
MSH3ENST00000670357.1 linkn.-39C>T 5_prime_UTR_premature_start_codon_gain_variant Exon 1 of 25 ENSP00000499791.1
MSH3ENST00000670357.1 linkn.-39C>T non_coding_transcript_exon_variant Exon 1 of 25 ENSP00000499791.1
MSH3ENST00000265081.7 linkc.-39C>T 5_prime_UTR_variant Exon 1 of 24 1 NM_002439.5 ENSP00000265081.6
DHFRENST00000439211.7 linkc.-200G>A 5_prime_UTR_variant Exon 1 of 6 1 NM_000791.4 ENSP00000396308.2
MSH3ENST00000670357.1 linkn.-39C>T 5_prime_UTR_variant Exon 1 of 25 ENSP00000499791.1
MSH3ENST00000667069.1 linkc.-39C>T upstream_gene_variant ENSP00000499502.1

Frequencies

GnomAD3 genomes
AF:
0.134
AC:
20264
AN:
151422
Hom.:
1639
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0478
Gnomad AMI
AF:
0.144
Gnomad AMR
AF:
0.113
Gnomad ASJ
AF:
0.126
Gnomad EAS
AF:
0.0677
Gnomad SAS
AF:
0.241
Gnomad FIN
AF:
0.206
Gnomad MID
AF:
0.115
Gnomad NFE
AF:
0.178
Gnomad OTH
AF:
0.115
GnomAD2 exomes
AF:
0.156
AC:
30664
AN:
196436
AF XY:
0.166
show subpopulations
Gnomad AFR exome
AF:
0.0442
Gnomad AMR exome
AF:
0.0786
Gnomad ASJ exome
AF:
0.121
Gnomad EAS exome
AF:
0.0686
Gnomad FIN exome
AF:
0.201
Gnomad NFE exome
AF:
0.176
Gnomad OTH exome
AF:
0.150
GnomAD4 exome
AF:
0.169
AC:
238344
AN:
1408996
Hom.:
21775
Cov.:
26
AF XY:
0.172
AC XY:
120785
AN XY:
701824
show subpopulations
African (AFR)
AF:
0.0413
AC:
1216
AN:
29434
American (AMR)
AF:
0.0844
AC:
3482
AN:
41276
Ashkenazi Jewish (ASJ)
AF:
0.126
AC:
3132
AN:
24920
East Asian (EAS)
AF:
0.0672
AC:
2372
AN:
35278
South Asian (SAS)
AF:
0.240
AC:
19961
AN:
83192
European-Finnish (FIN)
AF:
0.201
AC:
9175
AN:
45594
Middle Eastern (MID)
AF:
0.134
AC:
751
AN:
5606
European-Non Finnish (NFE)
AF:
0.174
AC:
189290
AN:
1085462
Other (OTH)
AF:
0.154
AC:
8965
AN:
58234
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
9448
18896
28345
37793
47241
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
6530
13060
19590
26120
32650
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.134
AC:
20272
AN:
151528
Hom.:
1639
Cov.:
32
AF XY:
0.136
AC XY:
10053
AN XY:
74026
show subpopulations
African (AFR)
AF:
0.0478
AC:
1979
AN:
41438
American (AMR)
AF:
0.113
AC:
1720
AN:
15236
Ashkenazi Jewish (ASJ)
AF:
0.126
AC:
438
AN:
3466
East Asian (EAS)
AF:
0.0677
AC:
346
AN:
5108
South Asian (SAS)
AF:
0.242
AC:
1161
AN:
4804
European-Finnish (FIN)
AF:
0.206
AC:
2147
AN:
10438
Middle Eastern (MID)
AF:
0.124
AC:
36
AN:
290
European-Non Finnish (NFE)
AF:
0.178
AC:
12077
AN:
67732
Other (OTH)
AF:
0.112
AC:
237
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.495
Heterozygous variant carriers
0
845
1689
2534
3378
4223
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
240
480
720
960
1200
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.103
Hom.:
291
Bravo
AF:
0.117
Asia WGS
AF:
0.134
AC:
463
AN:
3456

ClinVar

Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not provided Benign:1
Jun 22, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.75
CADD
Benign
7.2
DANN
Benign
0.84
PhyloP100
-0.0080
PromoterAI
-0.030
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.0
Mutation Taster
=297/3
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1105525; hg19: chr5-79950508; COSMIC: COSV54143671; COSMIC: COSV54143671; API